Article Text

13 Development of Guidelines for Primary Prophylaxis for Venous Thromboembolism (VTE) in Palliative Patients with Malignancy Within the Pan birmingham Cancer Network
  1. Michelle Aslett
  1. Marie Curie and Solihull Care Trust and Compton Hospice

Statistics from

Background: The evidence available to balance risk and benefit from anticoagulation in palliative patients is scanty. There are no data available on the numbers of cancer patients needing treatment to prevent venous thromboembolism (VTE). The introduction of National Institute for Health and Clinical Excellence (NICE) guidelines looking at VTE prevention has put this topic high on trust agendas. Anecdotally, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.